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Abstract
Sphingolipidoses are severe, mostly infantile lysosomal storage disorders (LSDs) caused
by defective glycosphingolipid degradation. Two of these sphingolipidoses, Tay Sachs
and Sandhoff diseases, are caused by β-Hexosaminidase (HEXB) enzyme deficiency,
resulting in ganglioside (GM2) accumulation and neuronal loss. The precise sequence of
cellular events preceding, and leading to, neuropathology remains unclear, but likely
involves inflammation and lysosomal accumulation of GM2 in multiple cell types. We
aimed to determine the consequences of Hexb activity loss for different brain cell types
using zebrafish. Hexb deficient zebrafish (hexb−/−) showed lysosomal abnormalities
already early in development both in radial glia, which are the neuronal and glial progeni-
tors, and in microglia. Additionally, at 5 days postfertilization, hexb−/− zebrafish showed
reduced locomotor activity. Although specific oligosaccharides accumulate in the adult
brain, hexb−/−) zebrafish are viable and apparently resistant to Hexb deficiency. In all, we
identified cellular consequences of loss of Hexb enzyme activity during embryonic brain
development, showing early effects on glia, which possibly underlie the behavioral aber-
rations. Hereby, we identified clues into the contribution of non-neuronal lysosomal
abnormalities in LSDs affecting the brain and provide a tool to further study what under-
lies the relative resistance toHexb deficiency in vivo.
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1 | INTRODUCTION
Lysosomal storage disorders (LSDs) comprise a group of at least 55 disor-
ders, which are caused by genetic mutations in lysosomal enzymes lead-
ing to loss of protein function (Kielian, 2019). This typically leads to
storage of undigested material in lysosomes, and cellular dysfunction or
cell death. LSDs frequently involve progressive neurodegeneration, and
for most of them, there is no treatment available yet. How lysosomal dys-
function precisely leads to neurodegeneration in LSDs is not completely
understood. One LSD, Sandhoff disease, is caused bymutations in HEXB,
leading to deficiencies in β-Hexosaminidase hydrolases, formed either by
HEXA/B or HEXB/B dimers (Mahuran, 1991; Utsumi et al., 2002). Reces-
sive mutations in HEXA cause Tay-Sachs disease, which presents with
identical clinical pathology to SD (Gravel, Triggs-Raine, & Mahuran,†Equal contribution.
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1991). β-Hexosaminidase plays a role in ganglioside metabolism and
hydrolyzes GM2 gangliosides into GM3 gangliosides in lysosomes, which
in turn is further degraded by other lysosomal enzymes. Loss of
eitherHEXA orHEXB results in accumulation of the ganglioside GM2, and
therefore these disorders are clustered as GM2 gangliosidoses. GM2
accumulation is mainly found in brain cells, including neurons and glia
(Kawashima, Tsuji, Okuda, Itoh, & Nakayama, 2009; Kyrkanides et al.,
2012; Tsuji et al., 2005). It is unknown however, what molecular and cel-
lular events precede pathology and cause SD or Tay-Sachs disease.
In themost common and severe form of SD, symptoms appear during
infancy. At about 3 to 6 months after birth, after an initially normal post-
natal development, development slows down and skeletal muscles
weaken, causing loss of acquired motor abilities such as turning over, sit-
ting upright, and crawling (Hendriksz et al., 2004). Most symptoms are
neurological and include an exaggerated startle response to loud noises,
seizures, vision andhearing loss, intellectual disability, andparalysis. There
is no treatment available and infantile Sandhoff patients typically do not
live longer than 5 years (Hendriksz et al., 2004). Due to the very early
onset and rapid disease progression, the initial cellular events leading to
neuronal loss remain obscure.
SD neuropathology involves neuronal loss, the presence of increased
numbers of activated microglia—the brain's macrophages— and astro-
cytes (Jeyakumar et al., 2003; Myerowitz et al., 2002; Sargeant et al.,
2012). Expansion of both microglia and astrocyte numbers are in fact
found in many brain disorders including epilepsy, other LSDs, multiple
sclerosis, and neurodegenerative disorders, and likely play a role in patho-
genesis (Fakhoury, 2018; Geloso et al., 2017; Joe et al., 2018; Lee et al.,
2016; Oosterhof et al., 2018; Ponath, Park, & Pitt, 2018; Zhao et al.,
2018). In SD mice, GM2 storage is found in lysosomes of neurons, but
also in lysosomes of astrocytes and microglia (Kawashima et al., 2009;
Kyrkanides et al., 2012; Tsuji et al., 2005). Based on pathology and gene
expression data, it is still unclear which cell types are responsible for the
initiation and progression of the pathology. In SD mice, microglial activa-
tion was found to precede neurodegeneration (Wada, Tifft, & Proia,
2000). In microglia, HEXB is remarkably highly expressed compared to
expression in other brain cell types and even considered to be a microglial
signature gene (Artegiani et al., 2017; Bennett et al., 2018; Butovsky
et al., 2014; Gosselin et al., 2017; Hickman et al., 2013; Oosterhof et al.,
2017). Given that microglia are highly phagocytic, lysosomal function is
critical for processing ingested material and HEXB could also be impor-
tant for microglial function. Several studies showed that suppression of
microglial or astrocytic inflammation could reduce SD pathology,
suggesting both glial cells might be involved in SD pathogenesis (Tsuji
et al., 2005;Wada et al., 2000;Wu&Proia, 2004). It is important to deter-
mine if, and to what extent, HEXB deficiency also affects glial function or
if gliosis is a consequence of neuronal problems directly caused by the
loss of HEXB. Analysis of hexb−/−mouse fetal neuronal stem cells (NSCs),
also called radial glia, revealed a more frequent differentiation towards
the astrocyte lineage rather than neurons, indicating abnormal differenti-
ation of brain cells (Ogawa et al., 2017). SD patient IPS cell-derived
organoids also showed aberrant neuronal differentiation (Allende et al.,
2018). These studies suggest that HEXB deficiency could intrinsically
affect neuronal differentiation and induce increased astrocyte numbers,
which could be an initiating event in the pathogenesis of SD.
Potential therapeutic options for SD include gene therapy, immune
suppression, and bone marrow transplantation. Gene therapy in SD
mouse models, applied by intravenous viral transduction from postnatal
day one and two, prevented pathology (Niemir et al., 2018). However, the
subclinical disease process preceding the onset of symptoms makes early
intervention using gene therapy difficult to implement. Immune suppres-
sion or bone marrow transplantations improve neurological function in
SD mice, likely by reducing gliosis (Abo-Ouf et al., 2013; Ogawa et al.,
2017; Ogawa et al., 2018;Wada et al., 2000;Wu,Mizugishi, Bektas, San-
dhoff, & Proia, 2008). Although these therapies seem very promising, it is
important to understand to what extent such approaches are targeting
the cause, rather than inhibiting the symptoms. Therefore, understanding
the early cellular pathogenic processes will facilitate the development of
an effective treatment for SD.
Remarkably, natural occurring HEXB or HEXA variants leading to gan-
gliosidoses, have been observed in various domesticated as well as wild
vertebrate species including dogs, cats, sheep, Muntjak deer, and flamin-
gos (Cork et al., 1977; Kanae et al., 2007; Kolicheski et al., 2017; Martin
et al., 2004; Rahman et al., 2012; Torres et al., 2010; Zeng et al., 2008).
The disease course in these animals is similar to that in humans, showing
the conserved importance of proper processing of gangliosides. To under-
stand SD pathogenesis, we aimed to visualize the earliest lysosomal
abnormalities to discern the affected cell types during brain development
in vivo.We used the zebrafish as a model since their offspring develop ex
utero allowing the visualization of pathology in vivo using live imaging,
they have a relative small size and are transparent, and have previously
been used to study lysosomal (dys)function (Berg et al., 2016; Festa et al.,
2018; Keatinge et al., 2015; Li et al., 2017; Louwette et al., 2013; Shen,
Sidik, & Talbot, 2016). Moreover, zebrafish harbor a single HEXB homo-
log, hexb, and transgenic reporter lines are available to label different cell
types.We generated an SD zebrafish model in which we investigated the
earliest emergence of cell-type specific lysosomal abnormalities in the
developing brain. Already in the first days of brain development, we iden-
tified increased lysosomal volume in radial glia and altered lysosomal mor-
phology in microglia. With the present study, we identified some of the
cellular consequences of loss of Hexb enzyme activity during embryonic
brain development, showing early effects on glia, which possibly underlie
the behavioral aberrations.
2 | RESULTS
2.1 | Direct mutagenesis causes Hexb enzyme
deficiency and glial lysosomal abnormalities
Zebrafish Hexb shares ~64% sequence identity with the human protein,
and is encoded by a single hexb gene.We targeted hexb by injecting fertil-
ized zebrafish oocytes at the one-cell stage with Cas9 protein/gRNA
complex targeting exon 1 of hexb. To determine the efficiency of
targeting the zebrafish hexb locus, the generation of insertions and dele-
tions (InDels) was determined by Sanger sequencing genomic DNA from
individual 4 dpf larvae (n = 24). This was followed by sequence
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decomposition using TIDE showing that, on average, 94% of the alleles
harbor InDels (i.e., mutagenesis efficiency) (Figure 1a) (Brinkman, Chen,
Amendola, & van Steensel, 2014).We refer to the F0 generation of larvae
that are directly injected with Cas9 protein/gRNA complex as crispants.
HEXA and HEXB enzyme activity are both affected in SD patients.
Therefore, we analyzed β-Hexosaminidase (Hexa and Hexb) enzyme
activity in dissected heads of control and hexb crispants. Tail genomic
DNAof these larvae showed highly efficient (97–100%) InDel generation,
and, consistent with loss of Hexb activity, hexb crispants showed >95%
detectable reduction in substrate conversion by β-Hexosaminidase A + B
(Figure 1b).
HEXB is a microglial signature gene, and is one of the highest
expressed lysosomal enzymes in microglia (Artegiani et al., 2017;
Gosselin et al., 2017; Keren-Shaul et al., 2017; Oosterhof et al., 2017).
SD neuropathology includes microglial activation, and therefore we
hypothesized that Hexb deficiency would affect microglial lysosomes.
To visualize lysosomes in vivo we used lysotracker (LT) staining, which
labels all acidic organelles including lysosomes, and to visualize
microglia we used transgenic zebrafish in which GFP expression is
driven by the mpeg1-promotor (Berg et al., 2016; Ellett, Pase,
Hayman, Andrianopoulos, & Lieschke, 2011; Shen et al., 2016). At
4 dpf, although there were no major differences in microglial numbers,
F IGURE 1 Efficient mutagenesis in hexb crispants shows abnormal lysosomes in microglia and radial glia. (a) graph shows mutagenesis efficiency
for 24 injected fish at 4 dpf. Each dot represents 1 larva. (b) hexb crispants show almost no enzymatic conversion of substrate by β-Hexosaminidase
A + B at 4dpf. (c) Representative images of microglia in 8 dpf larvae imaged in the depicted area. Scale bar represents 20 μm. Quantification of
lysotracker (LT+) area within microglia relative to the total microglial area in 8 dpf larvae. Each dot represents 1 larva. (d) Expression pattern of the
tgBAC(slc1a2b:Citrine) transgenic line at 4 dpf, with magnification/sub-stack showing the radial fibers in the optic tectum, and a schematic showing
radial glia orientation and direction of neurogenic migration along the radial fibers. Scale bars represent 100 and 20 μm, respectively.
(e) Representative images of radial glia at 4 dpf in controls and in hexb crispants with quantification of relative LT+ signal per measured total area.
Each dot represents 1 larva. Scale bars represent 10 μm. Error bars represent SD [Color figure can be viewed at wileyonlinelibrary.com]
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lysosomal compartments of hexb deficient microglia were found to be
enlarged compared to those in controls, suggesting that Hexb defi-
ciency results in lysosomal abnormalities in microglia (Figure 1c,d).
Unexpectedly, however, we also observed numerous LT+ speckles
outside microglia that were more prominently present in hexb cri-
spants (Figure 1c; Movie S1). These speckles are most likely lyso-
somes of another cell type that is not fluorescently labeled in the
mpeg1 reporter line.
Astrocytes have been shown to accumulate gangliosides GM2 and
GA2 in postnatal Hexb−/− mice, and showed increased proliferation
(Kawashima et al., 2009). In zebrafish, radial glia has both astrocytic
and radial glia/neural stem cell properties (reviewed in: [Lyons & Tal-
bot, 2014]). For example, homologs of two mammalian astrocytes
genes, Slc1a2, encoding the glutamate transporter GLT-1, and Gfap,
are expressed in radial glia in zebrafish (slc1a2b and gfap) (McKeown,
Moreno, Hall, Ribera, & Downes, 2012). Similarly, astrocyte endfeet in
mammals express tight junction proteins, which in zebrafish are also
expressed particularly in radial glia (Corbo, Othman, Gutkin, Alonso
Adel, & Fulop, 2012; Marcus & Easter, 1995). We hypothesized that
the lysosomal puncta observed outside microglia in hexb crispants
may reside in radial glia (RG). We used bacterial artificial chromosome
(BAC)-recombineering to generate an slc1a2b fluorescent reporter
line, TgBAC(slc1a2b:Citrine), expressing Citrine in the cytoplasm of RG
(Figure 1d and Figure S1) (Bussmann & Schulte-Merker, 2011). In
slc1a2b:Citrine zebrafish, the fluorescent expression pattern appeared
highly similar to that observed by slc1a2b mRNA in situ hybridization,
showing cell bodies lining the ventricle and radial fibers extending
throughout the brain (Figure 1d and Figure S1) (Franceschi et al.,
2018; Gesemann, Lesslauer, Maurer, Schonthaler, & Neuhauss, 2010;
McKeown et al., 2012; Niklaus et al., 2017; Rohrschneider, Elsen, &
Prince, 2007). We next visualized lysosomes in RG of control and hexb
crispants. The majority, >80%, of LT+ speckles, both in control and in
hexb crispant larvae, showed colocalization with the radial fibers of
slc1a2b + RG (Movie S2; Figure S2). Quantification of the lysosomal
area in the imaged regions, which contain RG fibers and cell bodies,
showed more abundant lysosomes present in hexb crispants
(Figure 1e). Together, loss of Hexb enzyme activity results in abnormal
lysosomal phenotypes in both microglia and RG.
2.2 | Early abnormal lysosomal phenotypes both in
microglia and RG of hexb−/− larvae
To validate and further investigate the Hexb deficient phenotype,
which we observed in hexb crispants, we generated stable mutants
containing a 14 bp frame-shifting deletion in the first exon of hexb,
leading to 19 out of frame amino acids followed by a premature stop
codon (Figure 2a). To test whether this causes β-Hexosaminidase
(Hexa + Hexb) deficiency, we measured β-Hexosaminidase A + B
activity in lysates from control and hexb−/− larval heads, and also in
adult brain and internal organs—containing: intestine, liver, spleen,
pancreas, and gonads—, which showed that activity was reduced by
>99% (Figure 2b). Consistently, analysis of specific oligosaccharides,
which accumulate, as a consequence of HEXB deficiency, in adult
brain and internal organs—containing: intestine, liver, spleen, pancreas,
and gonads—, showed accumulation in both brain and internal organs
from hexb−/− fish, but was hardly or not detectable in brain or organs
from controls (Figure 2b). Surprisingly, adult hexb−/− zebrafish were
viable and do not show obvious motility defects.
We wanted to further explore the consequences of Hexb-
deficiency on brain function and development, and determined by LT
staining when lysosomal aberrations in microglia first appeared. We
first quantified LT-stained surface in control and hexb−/− microglia in
5 dpf larvae, which in contrast to the small but significant increase in
lysosomal volume that we observed in 8 dpf hexb crispants, showed
no changes (Figure 2c). However, detailed inspection of lysosomes in
hexb−/− and control microglia showed changes in lysosomal morphol-
ogy. Hexb−/− microglia showed fewer lysosomes consisting of a single
round compartment, but more lysosomes that seemed to consist of
clustered small lysosomes. To quantify this, we defined three lyso-
somal categories: spherical (lysosomes that consist of a large, single
round compartment), raspberry (lysosomes consisting of clustered
smaller compartments) and undefined (lysosomes with intermediate
morphology between those categories) (Figure 2d). At 3 dpf, lyso-
somal morphologies did not differ between controls and hexb−/−
brains, with the majority of lysosomes being raspberry shaped
(Figure 2d). In control microglia the fraction of raspberry-shaped lyso-
somes decreased over time between 3 and 5 dpf, whereas hexb−/−
microglia contained relatively more raspberry shaped lysosomes, and
fewer spherical shaped lysosomes (Figure 2d). This could indicate that
small lysosomal vacuoles in hexb−/− microglia fail to fuse and fail to
form a larger spherical vacuole, which can possibly be explained by
reduced phagocytic flux or reduced autophagosome fusion. Alterna-
tively, lower numbers of microglia could result in increased phagocytic
demand for the residual microglia, which could lead to altered lyso-
somal morphologies. To evaluate this possibility, we quantified
microglia numbers. Loss of Hexb activity did not affect microglial
numbers (Figure 2e), and therefore lower microglial numbers do likely
not cause the changes in lysosomal morphology.
To determine when the abnormal lysosomes in RG first appeared, we
imaged RG lysosomes in control and hexb−/− zebrafish, and quantified
lysosomal volume by measuring LT fluorescence in selected areas
(Figure 3a). At 3 dpf LT+ lysosomal speckles were abundantly present in
control and hexb−/− radial fibers (Figure 3c). Over time however, LT+
speckles became undetectable in control RG,whereas LT+ speckles in the
hexb−/− radial fibers becamemore abundant. At 5 dpf hexb−/− RG showed
significantly more LT+ speckles than controls did (Figure 3b,c). These LT+
speckles in the radial fibers were highlymotile, showing rapid and bidirec-
tional trafficking inside the radial glial fibers, in both controls and hexb−/−
larvae.
Since the hexb−/− larvae presented with lysosomal abnormalities
in microglia preceding those in RG, it is possible that abnormalities in
RG lysosomes occur secondary to a defect in microglia. Therefore, we
analyzed LT-staining in RG in csf1r mutant fish, containing almost no
microglia during early development (csf1rDM) (Oosterhof et al., 2018,
2019). These csf1rDM larvae did not retain LT+ speckles in radial fibers
of radial glia at 5 dpf, as we did observe in hexb−/− larvae (Figure 3b–
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F IGURE 2 Stable hexb−/− fish show impaired Hexb enzyme function and lysosomal abnormalities in microglia. (a) Schematic representation of
the hexb gene and the 18 bp gRNA and PAM motif. The hexb−/− fish show a 14 bp out of frame deletion disrupting part of the gRNA target
sequence and PAM motif, resulting in 19 out of frame amino acids (magenta) followed by a premature stop codon. (b) Enzymatic substrate
conversion by β-Hexosaminidase A + B in larval heads and adult brain and internal organs—containing: intestine, liver, spleen, pancreas and
gonads. Mass spectrometry analysis of Hexb deficiency associated oligosaccharide (OS) marker abundance based on exact mass (Hex2-HexNAc2,
747.267 (OS1); Hex3-HexNAc3, 1,112.399 (OS2); Hex3-HexNAc4, 1,315.479 (OS3)) in 1.5 year old hexb−/− and control brains and internal
organs—containing: intestine, liver, spleen, pancreas and gonads. (c) Representative images of microglia in LT-stained larvae at 5 dpf, scale bar
represents 100 μm. Quantifications were performed on detailed images of depicted regions, scale bar represents 10 μm. Quantification of relative
lysotracker area within microglia. (d) Classification of lysosomal morphology in microglia with their quantification at 3, 4, and 5 dpf. n = 4 to
6 larvae per group. Scale bars represent 10 μm. (e) Quantification of total microglia in the imaged regions. Error bars represent SD. Each dot
represents 1 larva [Color figure can be viewed at wileyonlinelibrary.com]
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F IGURE 3 Hexb−/− larvae show increased number of lysosomal speckles in radial glia. (a) Representative image of tgBAC(slc1a2b:Citrine)
expression in 5 dpf larval brain with magnifications of radial protrusions in the optic tectum. Scale bars represent 100 μm and 20 μm respectively.
(b) Representative images of radial glia in LT stained larvae at 5 dpf in areas quantified in (c). Scale bar represents 20 μm. The brightness of the
control LT image was enhanced to indicate the presence of some LT+ speckles. (c) Quantification of LT coverage, in percentage, within quantified
areas. Each dot represents one larva. Error bars represent SD. (d) Representative images of control and csf1rDM larvae at 5 dpf, stained with LT
and quantification. Scale bar represents 20 μm [Color figure can be viewed at wileyonlinelibrary.com]
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d). Quantitative analysis however did show increased LT+ staining in
RG of csf1rDM larvae compared to control larvae (Figure 3d). However,
the majority of the LT staining in csf1rDM radial glia do not appear as
speckles but rather as larger lysosomes (Figure 3d, Movie S5). These
lysosomes appear in structures that look like phagolysosomes,
suggesting radial glia of csf1rDM larvae are phagocytic, but do not
retain LT+ speckles in tremendous amounts like we observed in hexb
mutants (Puñal et al., 2019) (Movie S5, Figure 3b–d). In all, we show
that loss of Hexb activity early in embryonic development results in
the persistence of enlarged lysosomal speckles in RG fibers, likely
independent of microglia.
2.3 | hexb−/− deficiency causes reduced locomotor
activity and increased apoptosis in the brain
The earliest symptoms that present in SD patients are loss of muscle
strength and reduced motor function, both of which are likely caused
by atrophy of the innervating lower and/or upper motor neurons.
Therefore, we also measured locomotor activity under light and dark
conditions in control and hexb−/− fish. Zebrafish show stereotypical
locomotor responses to shifts in light/dark conditions as early as
24 hpf (Burgess & Granato, 2007; Kokel et al., 2010; MacPhail et al.,
2009). Locomotor activity over repeated light–dark cycles was
recorded by infrared imaging and measured by automated tracking.
Although control and hexb−/− larvae both responded to light/dark
switches, hexb−/− larvae showed reduced locomotor activity, which
was consistently detected at 4, 5, and 6 dpf (n = 24 per group, per
experiment) (Figure 4a). This test mainly focuses on the behavioral
response to shifts in light intensity, whereas we were mainly inter-
ested in general locomotor activity. Therefore, we developed a loco-
motor assay consisting of gradually increasing and decreasing light
intensities, mimicking more physiological relevant changes regulating
circadian behavior. Hexb−/− larvae showed >50% less locomotor activ-
ity during the light periods in this dusk/dawn cycle assay (Figure 4b).
These findings indicate that reduced locomotor activity of hexb−/−
larvae is not due to a defect in the behavioral response to light/dark
changes, but due to overall reduced locomotor activity compared to
controls. Thus, hexb−/− larvae show abnormally low locomotor activ-
ity, which coincides with the timing of appearance of glial lysosomal
abnormalities in the brain.
SD pathology is characterized by extensive loss of neurons. Dur-
ing normal vertebrate brain development extensive apoptosis occurs,
and in zebrafish developmental apoptosis in brain development is par-
ticularly high at 3 and 4 dpf (Cole & Ross, 2001; Sierra et al., 2010;
Southwell et al., 2012; van Ham, Kokel, & Peterson, 2012; Xu, Wang,
Wu, Jin, & Wen, 2016). To determine whether there is more apoptosis
in hexb−/− brains, we used transgenic zebrafish expressing secreted
fluorescently labeled Annexin V to analyze apoptotic cells (Morsch
et al., 2015). We did not detect differences in the number of Annexin
V+ apoptotic cells or debris at 3, 4, 5, and 7 dpf (Figure 4d). We also
performed TUNEL labeling, which stains late-apoptotic cells, in 5 day-
old brains and observed despite the low numbers of late-apoptotic
cells an ~twofold increase in the hexb−/− brains (Figure 4c). Taken
together, Hexb deficiency in zebrafish leads to reduced locomotor
activity, more late-apoptotic cell numbers in the brain at Day 5, but
no increase in overall apoptotic debris between Days 3 and 7.
3 | DISCUSSION
Here we generated hexb−/− zebrafish, which are β-Hexosaminidase
enzyme-deficient, and their pathology mimics molecular, cellular and
behavioral phenotypes that are also observed in HEXB-deficient San-
dhoff disease patients. Already within 5 days of development, hexb−/−
larvae presented with abnormal lysosomes in microglia and in radial
glia. The appearance of abnormal lysosomes in glia coincided with
reduced locomotor activity. These phenotypes were observed both in
Cas9/hexb gRNA injected and in hexb−/− larvae, which indicates that
crispants are a very suitable method to rapidly screen for pathologic
phenotypes, also for other lysosomal or metabolic diseases. Based on
our zebrafish model, the early presentation of abnormal lysosomes in
glial cells implies that pathogenesis might be characterized by dys-
functional glial cells in the first stages of SD.
Both in controls and hexb−/− RG, we observed abundant lysosomal
speckles in the radial fibers, at 3 and 4 dpf. In controls, the lysosomal
speckles were largely undetectable by 5 dpf, whereas in hexb−/− fish
these abundant RG lysosomes persisted or remained enlarged.
Enlarged lysosomal compartments are a characteristic of LSDs. This
suggests that, to resolve lysosomes in RG, β-Hexosaminidase enzyme
activity is required, and could imply that extensive processing of
sphingolipids such as GM2 occurs at this stage of brain development.
To determine whether microglial function might be involved in the
resolution of LT+ speckles in radial glia we analyzed csf1rDM larvae,
which are almost devoid of microglia (Oosterhof et al., 2018). The
absence of LT+ speckles in radial glia of microglia-less mutants shows
that the resolution of speckles occurs independently of microglia.
Therefore, Hexb activity seems required cell autonomously to resolve
LT+ speckles in radial glia. We did however find increased volume of
LT staining in RG of csf1rDM larvae, but these appear different from
the LT+ speckles observed in hexb mutants, as they are larger in size
and located in phagolysosome-like structures. Since radial glia or
astrocytes may take over phagocytic functions usually performed by
microglia, these large LT+ lysosomes could be the result of phagocytic
activity of radial glia in the absence of microglia in csf1rDM larvae
(Puñal et al., 2019). Importantly, RG in vertebrates are neuronal stem
cells, and are thought to produce most neurons, but also astrocytes
and oligodendrocytes (Doetsch, 2003). This process requires exten-
sive membrane remodeling involving synthesis and degradation of
membrane lipids, including glycolipids, in which lysosomes play a key
role (Jaishy & Abel, 2016; Kolter & Sandhoff, 2010; Sild, Van Horn,
Schohl, Jia, & Ruthazer, 2016). Consistent with this idea, differentia-
tion of RG into astrocytes in mice was accompanied by an increase in
lysosomes and autophagosomes (Gressens, Richelme, Kadhim,
Gadisseux, & Evrard, 1992). Furthermore, differentiation of SD-
patient iPSC-derived RG to neurons and astrocytes was skewed
towards astrocyte development (Ogawa, Kaizu, et al., 2017). Based on
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F IGURE 4 Locomotor activity assay shows abnormal locomotor activity in hexb−/− larvae. (a) Representative graph showing the locomotor
responses of larvae to alternating light and dark periods indicated by white and black squares in one single experiment. The dot plot shows the
quantification of the sum distance moved during all the light and all the dark periods. (b) Representative graph showing the total distance
travelled by larvae during the dusk-dawn routine (total time: 3 hr 12 min). Quantification of the total distance moved throughout the experiment
excluding the dark period. (a, b) n = 24 larvae per genotype. Grey shading shows the standard error of the mean. (c) Representative images of
control and hexb−/− larvae at 4 dpf transiently expressing secreted annexin V tagged with mVenus. Quantification of annexin V positive objects at
3, 4, 5, and 7 dpf. Scale bar represents 100 μm. (d) Representative images of TUNEL staining at 5 dpf with quantifications. Each dot represents
one larva. Scale bar represents 20 μm. Error bars represent SD unless stated otherwise [Color figure can be viewed at wileyonlinelibrary.com]
1712 KUIL ET AL.
these findings, the persistence or enlargement of lysosomal speckles
that we observed in hexb−/− RG in vivo, could be the result of
impaired glycolipid metabolism, essential for membrane remodeling,
and this could influence differentiation towards neurons and glia.
The hexb mutant locomotor phenotype is likely the consequence
of alterations in the brain, as we did not observe obvious alterations
in peripheral motorneurons and neuromuscular junctions (data not
shown), whereas aberrant lysosomes in glia are already detected at
these early stages. The reduced locomotor activity could be the result
of lysosomal dysfunction in either microglia or RG. Microglia have
essential functions for brain hemostasis, including clearance of apo-
ptotic cells, myelin remodeling and synaptic pruning (Hagemeyer
et al., 2017; Paolicelli et al., 2011; Reemst, Noctor, Lucassen, & Hol,
2016; Safaiyan et al., 2016; Sierra et al., 2010; Wlodarczyk et al.,
2017). Defects in such processes could perhaps contribute to defects
in locomotor control in the hindbrain leading to locomotor aberrations
(Chong & Drapeau, 2007; Kimura et al., 2013). RG on the other hand
produce neurons in the brain and alterations in neurogenesis during
early development likely affects brain circuitry formation, which could
also explain the reduced locomotor activity.
Gangliosidoses due to HEXA or HEXB mutations are associated
with severe neurological symptoms that often precede early lethality.
These diseases have been described in several mammalian species,
including dogs, cats, and Muntjak deer, and even in birds as Hexa defi-
ciency has been observed in Flamingo's (Cork et al., 1977; Kanae
et al., 2007; Kolicheski et al., 2017; Martin et al., 2004; Rahman et al.,
2012; Torres et al., 2010; Zeng et al., 2008). hexb deficient zebrafish
seem to recapitulate early disease stages, but lack extensive neu-
rodegeneration. In addition, adult homozygous hexb−/− zebrafish, even
though they lack Hexb activity, are viable and do not show obvious
behavioral symptoms. To the best of our knowledge, zebrafish are the
first vertebrate species tested that do not succumb to pathology cau-
sed by loss of Hexb activity. Mice deficient in Hexa do not have a
severe phenotype as they can bypass the need for HEXBA
heterodimer activity by an alternative pathway requiring a sialidase,
NEU3, to degrade gangliosides (Seyrantepe et al., 2018). Mass spec-
trometry analysis of oligosaccharides in zebrafish brains, however, did
show the presence of specific oligosaccharides, which accumulate as a
consequence of HEXB deficiency, suggesting there is no alternative
conversion route active in zebrafish. This suggests that zebrafish are,
perhaps to a certain extent, resistant to Hexb deficiency. In addition,
zebrafish, in contrast to mammalian species, can regenerate brain tis-
sue and produce new neurons throughout life (Becker & Becker,
2008; Becker & Becker, 2014; Caldwell et al., 2019; Kizil, Kaslin,
Kroehne, & Brand, 2012).
In conclusion, hexb−/− zebrafish show loss of enzyme activity,
accumulation of oligosaccharides, lysosomal abnormalities in glia and
reduced locomotor activity, reminiscent of the molecular, cellular,
neuropathological, and motility aspects of Sandhoff disease. The very
early accumulation of lysosomes in radial processes of RG and
raspberry-shaped lysosomes in microglia, occurring apparently inde-
pendently of cell death in the brain, may represent early events in
pathogenesis. These Hexb deficient zebrafish could be used to further
dissect cellular mechanisms that render them resistant to the effects
of Hexb deficiency, which leads to disease in various other species,
and to identify small molecules that suppress the earliest emergence
of cellular pathogenic features.
4 | MATERIALS AND METHODS
4.1 | Zebrafish larvae husbandry
Zebrafish embryos and larvae were kept at 28C on a 14–10-hour
light–dark cycle in 1 M HEPES buffered (pH 7.2) E3 medium (34.8 g
NaCl, 1.6 g KCl, 5.8 g CaCl2  2H2O, 9.78 g MgCl2  6 H2O). The
medium was changed at 1 dpf to E3 + 0.003% 1-phenyl 2-thiourea
(PTU) to prevent pigmentation. Larvae used for swimming assays
were kept in media without PTU. Transgenic lines used were
Tg(mpeg1:GFP) (Ellett et al., 2011) (Lieschke Laboratory, Clayton,
Australia) and TgBAC(slc1a2b:Citrine)re01tg, generated in our lab with
an TL background. The csf1raj4e1/j4e1csf1rbre01/re01 line was used,
referred to as csf1rDM (Oosterhof et al., 2018; Parichy, Ransom, Paw,
Zon, & Johnson, 2000). Animal experiments were approved by the
Animal Experimentation Committee at Erasmus MC, Rotterdam.
4.2 | Generation of the tgBAC(slc1a2b:Citrine)
reporter line
To generate the tgBAC(slc1a2b:Citrine)re01tg reporter line we used the
following clone DKEY-49F8 (HUKGB735F0849Q) in the pIndigoBAC-
536 vector. To perform recombination to insert tol2 sites and the
cytoplasmic Citrine, the BAC recombineering protocol developed by
Bussmann and Schulte-Merker (2011) was used. Primers are
described in Table 1.
4.3 | CRISPR-Cas9 genome editing in zebrafish
Hexb specific guideRNAs (gRNAs) were designed and synthetized by
transcribing from PCR fragment containing a T7 promoter as
described previously (Kuil et al., 2018; Moreno-Mateos et al., 2015).
To target the hexb gene the online program CRISPRscan was used to
design an 18 bp complementary gRNA targeting exon 1 (New Haven,
CT) (Moreno-Mateos et al., 2015) (Table 2). PCR fragments containing
a T7 promoter and gRNA sequence were generated by FastStart™
High Fidelity PCR System (Sigma, St. Louis, MO) as described
(Moreno-Mateos et al., 2015). To transcribe gRNAs from PCR frag-
ments the mMESSAGE mMACHINE™ T7 ULTRA Transcription Kit
(Invitrogen, Carlsbad, CA) was used according to the manufacturer's
instructions followed by RNA cleanup and determination of the qual-
ity and concentration by agarose gel electrophoresis and using
NanoDrop™ (ThermoFisher, Waltham, MA). Hexb specific gRNA
600–900 ng of the synthesized gRNA was mixed with 4 ng of Cas9
nuclease (Sigma, St. Louis, MO). The volume was adjusted with
300 mM KCl to a total volume of 6 μL. Approximately 10 nL of the
mix was injected in fertilized zebrafish oocytes. Genomic DNA sur-
rounding the gRNA target site was sequenced using Sanger
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sequencing and indel efficiency was determined using the online tool
TIDE (Brinkman et al., 2014) (Table 2). Founders were selected by
sequencing DNA from the tails of adult zebrafish, fish containing
mainly 14 bp deletions were selected for breeding. F1 fish were gen-
otyped and selected for −14 bp deletions using sanger sequencing.
Mutant fish containing −14 bp mutations in hexb are called hexbre04,
but referred to as hexb−/− throughout this report.
4.4 | LysoTracker staining
Zebrafish larvae were incubated in 1.5 mL tubes with 10 μM
LysoTracker™ Red DND-99 (1:100) (ThermoFisher, Waltham, MA) in
100 μL E3-PTU. The tube was kept at 28C for 40 min with the lid
open and protected from light. The media was replaced by E3-PTU
only and the fish were mounted after at least 10 min to wash away
excess dye.
4.5 | TUNEL staining
For staining larvae were euthanized on ice, followed by fixation in 4%
paraformaldehyde in PBS at 4C overnight, permeabilized by protein-
ase K (10 μg/mL) in PBST treatment for 40 min and refixed in PFA for
20 min at room temperature. TUNEL staining was performed as previ-
ously described using the Click-iT TUNEL Alexa Fluor 647 Kit
(Invitrogen, Carlsbad) (C10247) (van Ham, Mapes, Kokel, & Peterson,
2010). TUNEL+ cells in the whole brain were quantified.
4.6 | Plasmid microinjection
To visualize apoptotic cells we injected fertilized oocytes with the
ubiq:secAnnexinV-mVenus plasmid, which was kindly provided by
Dr. Marco Morsch, Macquarie University, Sydney (Morsch et al.,
2015; van Ham et al., 2010). mVenus positive larvae were selected for
confocal microscopy.
4.7 | Mass spectrometric analysis of oligosaccharides
Tissues were obtained from adult zebrafish, euthanized on ice water, by
microdissection as described (Oosterhof et al., 2018). Tissue samples
were homogenized in 80 μL water, containing 18 μmol/L tri-
acetylchitotriose and 18 μmol/L hexa-acetylchitohexaose as internal
standards, using a Potter-Elvehjem tube, followed by sonication at
130 W for 10 s on ice. Insoluble material was removed by centrifugation
at 13,000g for 10 min. The supernatant was dried under nitrogen flow at
40C and the resulting residue was dissolved in 80 μL water. The follow-
ing oligosaccharides were determined semiquantitatively using high-
resolution mass spectrometry: Hex2-HexNAc2, Hex3-HexNAc3, and
Hex3-HexNAc4 (Bonesso et al., 2014). Chromatography was performed
using a Thermo Scientific Ultimate 3,000 UHPLC system, equipped with
a BEHAmide column (Waters 2.1× 50 mm, 1.7 μmparticle size). Analytes
were separated by a gradient LC method using mobile phase consisting
eluent A (10 mM ammonium acetate in 10:90 water/acetonitrile + 0.1%
w/v ammonium hydroxide) and B (10 mM ammonium acetate in 70:30
water/acetonitrile adjusted to pH 9 with ammonium hydroxide) at a flow
TABLE 1 Primers used for BAC recombineering
Primer name Primer sequence
pIndigoBAC_HA1_iTol2_fw 50-ttctctgtttttgtccgtggaatgaacaatggaagtccgagctcatcgctCCCTGCTCGAGCCGGGCCCAAGTG-30
pIndigoBAC_HA2_iTol2_rev 50-agccccgacacccgccaacacccgctgacgcgaaccccttgcggccgcatATTATGATCCTCTAGATCAGATC-30
pTarBAC_HA1_control_fw 50-CTGTCAAACATGAGAATTGGTC-30
amp_HA1_control_rev 50-ACATTTCCCCGAAAAGTGG-30
amp_HA2_control_fw 50-CTGAGATAGGTGCCTCACTG-30
pIndigoBAC_HA2_control_rev 50-TGGTGCACTCTCAGTACAATC-30
Citrine_HA1_control_rev 50-GGACACGCTGAACTTGTGG-30
kanR_HA2_control_fw 50-TCCTCGTGCTTTACGGTATC-30
slc1a2b HA1 GFP fw 50-GACCCAGATGTGTGCTGTTGTTCATCTGCTCTGTTTCTCCGCAGTTGTGGACCATGGTGAGCAAGGGCGAGGAG-30
slc1a2b HA2 KanR rev 50-TCGATGGGCTCCAGGTGGCTTTCGTGCATCCGTACCTCCACGTGCTTCGGTCAGAAGAACTCGTCAAGAAGGCG-30
slc1a2b HA1 control fw 50-CTCGACTGTGGTGACCTGTG-30
slc1a2b HA2 control rev 50-AGGTTCTTCCGCATCTTCTGG-30
TABLE 2 Primers used for gRNA synthesis and sanger sequencing
Primer name Primer sequence
hexb gRNA fw taatacgactcactataGGGTCCGGCGGTGGACTGTTgttttagagctagaa
gRNA synthesis rev GATCCGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC
hexb sequencing fw GCTCAACACAACCATGCTCT
hexb sequencing rev ATGTGATCCATACCTGCAGC
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rate of 0.40 mL/min. The gradient composition was as follows: 1% B at
the start, from 1 to 50% B in 1.5 min, from 50 to 95% B in 1 min, 95% B
for 2 min, from 95 to 1% B in 0.5 min, and finally 1% B for 4 min before
the next sample injection. Injection volume was 0.7 μL and column tem-
perature was maintained at 40C. Detection was done on a Thermo
Scientific QExactive Plus in the full scan mode using the following exact
masses (negative mode; -H): Hex2-HexNAc2, 747.267 (OS1);
Hex3-HexNAc3, 1,112.399 (OS2); Hex3-HexNAc4, 1,315.479 (OS3). For
each of these oligosaccharides a single peak was obtained with a mass
accuracy <3 ppm. Approximate quantification of oligosaccharides was
done by comparison of the oligosaccharide peak area's with that of the
internal standards.
4.8 | Fluorescence microscopy imaging
Zebrafish were anesthetized using tricaine (0.016%) and mounted in
1.8% low melting point agarose. The imaging dish was covered with
HEPES-buffered E3 containing tricaine during imaging. Larvae were
imaged on a Leica SP5 intravital microscope with multiphoton laser
using a 20×water dipping objective (Leica Plan-Apochromat, NA = 1.0)
using 488 and 561 laser lines. Confocal z-stack images were acquired.
Images were processed with ImageJ software.
4.9 | β-Hexosaminidase activity assay
Heads were dissected from 4 dpf control larvae and hexb crispants or
mutants, after euthanizing them with ice water and a tricaine overdose,
and analyzed for enzymatic activity. Adult pools of 2 or 3 dissected
heads were grouped according to their genotype and homogenized
using sonication in 100 μL H2O. For adult organs, animals were eutha-
nized using ice water, Protein concentration was measured using BCA
reagent by spectrophotometry after 1-hr incubation at 37C (Pierce).
The substrate, 5 mM MU-β-GlcNAc in 0.2 M Na-phosphate/0.1 M cit-
rate buffer, pH 4.4 + 0.02% (w/v) NaN3, was added to each lysate pool,
including one replicate per sample, and incubated for 1-hr at 37C in
which β-Hexosaminidase will form 4-MU. After addition of 0.5 M
Na2CO3 buffer, pH 10.7, 4-MU fluorescence was measured and nor-
malized to the blank (substrate alone). The final read-out consisted of
nmoles of 4-MU released per hour per mg of protein.
4.10 | Locomotor activity assays
To assess the locomotor activity of zebrafish larvae from 3 to 5 dpf,
locomotor activity assays were performed using an infrared camera
system (DanioVision™ Observation chamber, Noldus) and the using
EthoVision® XT software (Noldus). Control (n = 24) and hexb−/−
(n = 24) zebrafish larvae, in 48 well plates, were subjected to two dif-
ferent light/dark routines. The White Light routine consisted of a
30 min habituation period, followed by 4 cycles of 15 min of light
(100%)/ 15 min darkness 15 (2.5 hr total). The Dawn routine 30 min
habituation in the dark (0% light intensity), followed by the routine
described in Table 3 and comprised 3 hr 12 min. Each experiment was
performed twice for the three ages (3, 4, and 5 dpf) with n = 24 con-
trols, and n = 24 mutants per experiment. Distance traveled (mm) per
second was measured.
4.11 | Statistical analysis
To measure mpeg1:GFP and LysoTracker volumes in confocal micro-
scopic imaging data, images were analyzed using automatic thresholding
in Fiji/ImageJ. The area of the LysoTracker inside mpeg1:GFP+ cells was
measured, by generating a mask for microglia in FIJI, and compared to
the total mpeg1:GFP+ area. For the Lysotracker areas of the radial glia,
images were automatically thresholded and the total LT+ area per image
was counted using the Analyze Particles plug-in (FIJI). For the radial glia
measurements, quantification the total LT+ area relative to total imaged
area was used. To quantify the annexin V signal we used the 3D object
counter plug-in (FIJI). For image processing and quantitative analysis,
Excel (Microsoft), Prism (Graphpad) and ImageJ were used. Statistical sig-
nificance was calculated using Student's t test. Error bars indicate stan-
dard deviation (SD) and p < .05 was considered significant. Symbols in
the graphs (*; **; ***) display levels of significance (p < .05; p < .01;
p < .001 respectively).
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